Article
Radiotherapy for asymptomatic brain metastasis in epidermal growth factor receptor mutant non-small cell lung cancer without prior tyrosine kinase inhibitors treatment: a retrospective clinical study.
Radiation oncology (London, England) - 27 May 2015
Liu SongRan, Qiu Bo, Chen LiKun, Wang Fang, Liang Ying, Cai PeiQiang, Zhang Li, Chen ZhaoLin, Liu ShiLiang, Liu MengZhong, Liu Hui
Abstract excerpt
BACKGROUND: Non-small cell lung cancer (NSCLC) with brain metastasis (BM) harboring an epidermal growth factor receptor (EGFR) mutation shows good response to tyrosine kinase inhibitors (TKIs). This study is to assess the appropriate timing of brain radiotherapy (RT) for asymptomatic BM in EGFR mutant NSCLC patients. METHODS: There were 628 patients diagnosed with EGFR mutant NSCLC between October 2005 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
